Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects

Ronald Swanstrom, Ronald J. Bosch, David Katzenstein, Hailong Cheng, Hongyu Jiang, Nicholas Hellmann, Richard Haubrich, Susan A. Fiscus, Courtney V Fletcher, Edward P. Acosta, Roy M. Gulick

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We analyzed retrospectively, by use of logistic regression, the role of the phenotypic susceptibility score (PSS) as a determinant of virologic outcome in a study of treatment-experienced human immunodeficiency virus (HIV) type 1-infected subjects. A model for PSS in which each drug was treated equally and scored as active or inactive was not predictive of HIV-1 RNA load (VL) suppression. However, weighting the potential contribution of each drug on the basis of inferred potency and by use of a continuous scale to quantify drug susceptibility revealed significant associations between PSS and outcome. Entry VL was a strong independent predictor of therapy outcome, and PSS was a strong predictor of the magnitude of the initial decrease in VL. This suggests that the prospective evaluation of PSS to identify regimens that maximize decreases in VL to reduce the probability of virologic rebound could improve antiretroviral treatment.

Original languageEnglish (US)
Pages (from-to)886-893
Number of pages8
JournalJournal of Infectious Diseases
Volume190
Issue number5
DOIs
StatePublished - Sep 1 2004

Fingerprint

Protease Inhibitors
HIV-1
RNA
Pharmaceutical Preparations
Logistic Models
Therapeutics

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. / Swanstrom, Ronald; Bosch, Ronald J.; Katzenstein, David; Cheng, Hailong; Jiang, Hongyu; Hellmann, Nicholas; Haubrich, Richard; Fiscus, Susan A.; Fletcher, Courtney V; Acosta, Edward P.; Gulick, Roy M.

In: Journal of Infectious Diseases, Vol. 190, No. 5, 01.09.2004, p. 886-893.

Research output: Contribution to journalArticle

Swanstrom, R, Bosch, RJ, Katzenstein, D, Cheng, H, Jiang, H, Hellmann, N, Haubrich, R, Fiscus, SA, Fletcher, CV, Acosta, EP & Gulick, RM 2004, 'Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects', Journal of Infectious Diseases, vol. 190, no. 5, pp. 886-893. https://doi.org/10.1086/422692
Swanstrom, Ronald ; Bosch, Ronald J. ; Katzenstein, David ; Cheng, Hailong ; Jiang, Hongyu ; Hellmann, Nicholas ; Haubrich, Richard ; Fiscus, Susan A. ; Fletcher, Courtney V ; Acosta, Edward P. ; Gulick, Roy M. / Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects. In: Journal of Infectious Diseases. 2004 ; Vol. 190, No. 5. pp. 886-893.
@article{ae66fb0dbb3f461482f10f4d93a9b465,
title = "Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects",
abstract = "We analyzed retrospectively, by use of logistic regression, the role of the phenotypic susceptibility score (PSS) as a determinant of virologic outcome in a study of treatment-experienced human immunodeficiency virus (HIV) type 1-infected subjects. A model for PSS in which each drug was treated equally and scored as active or inactive was not predictive of HIV-1 RNA load (VL) suppression. However, weighting the potential contribution of each drug on the basis of inferred potency and by use of a continuous scale to quantify drug susceptibility revealed significant associations between PSS and outcome. Entry VL was a strong independent predictor of therapy outcome, and PSS was a strong predictor of the magnitude of the initial decrease in VL. This suggests that the prospective evaluation of PSS to identify regimens that maximize decreases in VL to reduce the probability of virologic rebound could improve antiretroviral treatment.",
author = "Ronald Swanstrom and Bosch, {Ronald J.} and David Katzenstein and Hailong Cheng and Hongyu Jiang and Nicholas Hellmann and Richard Haubrich and Fiscus, {Susan A.} and Fletcher, {Courtney V} and Acosta, {Edward P.} and Gulick, {Roy M.}",
year = "2004",
month = "9",
day = "1",
doi = "10.1086/422692",
language = "English (US)",
volume = "190",
pages = "886--893",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Weighted phenotypic susceptibility scores are predictive of the HIV-1 RNA response in protease inhibitor-experienced HIV-1-infected subjects

AU - Swanstrom, Ronald

AU - Bosch, Ronald J.

AU - Katzenstein, David

AU - Cheng, Hailong

AU - Jiang, Hongyu

AU - Hellmann, Nicholas

AU - Haubrich, Richard

AU - Fiscus, Susan A.

AU - Fletcher, Courtney V

AU - Acosta, Edward P.

AU - Gulick, Roy M.

PY - 2004/9/1

Y1 - 2004/9/1

N2 - We analyzed retrospectively, by use of logistic regression, the role of the phenotypic susceptibility score (PSS) as a determinant of virologic outcome in a study of treatment-experienced human immunodeficiency virus (HIV) type 1-infected subjects. A model for PSS in which each drug was treated equally and scored as active or inactive was not predictive of HIV-1 RNA load (VL) suppression. However, weighting the potential contribution of each drug on the basis of inferred potency and by use of a continuous scale to quantify drug susceptibility revealed significant associations between PSS and outcome. Entry VL was a strong independent predictor of therapy outcome, and PSS was a strong predictor of the magnitude of the initial decrease in VL. This suggests that the prospective evaluation of PSS to identify regimens that maximize decreases in VL to reduce the probability of virologic rebound could improve antiretroviral treatment.

AB - We analyzed retrospectively, by use of logistic regression, the role of the phenotypic susceptibility score (PSS) as a determinant of virologic outcome in a study of treatment-experienced human immunodeficiency virus (HIV) type 1-infected subjects. A model for PSS in which each drug was treated equally and scored as active or inactive was not predictive of HIV-1 RNA load (VL) suppression. However, weighting the potential contribution of each drug on the basis of inferred potency and by use of a continuous scale to quantify drug susceptibility revealed significant associations between PSS and outcome. Entry VL was a strong independent predictor of therapy outcome, and PSS was a strong predictor of the magnitude of the initial decrease in VL. This suggests that the prospective evaluation of PSS to identify regimens that maximize decreases in VL to reduce the probability of virologic rebound could improve antiretroviral treatment.

UR - http://www.scopus.com/inward/record.url?scp=4344623482&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4344623482&partnerID=8YFLogxK

U2 - 10.1086/422692

DO - 10.1086/422692

M3 - Article

VL - 190

SP - 886

EP - 893

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

IS - 5

ER -